You searched for "laryngological"

1552 results found

What we need to know about the new frontier of inner ear therapies

This is an interesting and topical review of the emerging biotechnology and pharmaceutical solutions for hearing loss and related conditions such as tinnitus. This paper suggests we are on the cusp of a very large step-change in the way we...

Pharmacological treatment of glue ear in children

Otitis media with effusion (OME), also known as glue ear, is a common cause of hearing loss in children. Most cases resolve spontaneously within three months. Early and proper management of OME can help avoid hearing and speech impairment that...

Spirituality and tinnitus – blocking out the haters!

The brain is fantastic at blocking out unwanted noise. Place a microphone on your temporal bone and you’ll realise you are subject to a relentless bombardment of sound you’ll never consciously hear: the clicking of your temporomandibular joint, the pulsating...

Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen

This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...

Can smaller cancer centres deliver high quality care for patients with laryngeal cancer?

There is a continuing conflict between treating patients as close to their homes as possible and centralising specialised services, taking into consideration the critical mass and the multi-disciplinary expertise available. This is a report of outcomes in the treatment of...

ERS Abstract submission

The 30th Congress of the European Rhinological Society will take place in Budapest, Hungary, in June 2025. The ERS-ISIAN-IRS 2025 committees have decided to extend the submission date for abstracts to: 17 February 2025 CET 23:59.

Evidence-based hospital management of epistaxis

Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Audiology in this issue... The Changing World of Computational Audiology

Deborah Vickers, PhD, Principal Research Fellow in Hearing & Deafness, University of Cambridge, UK. E: dav1000@cam.ac.ukTwitter: @SOUNDLabCam / @DebiVickers_ / @BEARS_CIwww-neurosciences.medschl.cam.ac.uk/sound-lab/ Lorenzo Picinali, Reader in Audio Experience Design, Imperial College London, UK. E: l.picinali@imperial.ac.uk ENT & Audiology News Jan/Feb 2022...

New RSM presidents preview the year ahead

Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.

Adolescence, drug use and body image

Teenagers are notoriously conscious of how they are perceived by others. Dr Saraiva and colleagues explain how this can lead to problems with substance abuse for both boys and girls, and discuss the different substances they may encounter. Adolescence is...

Patient barriers: adult cochlear implantation systematic review

The literature across a 35-year time span highlights disproportionately low rates of cochlear implantation among adults compared to paediatric populations, despite the significant benefits of cochlear implants (CIs) for individuals with severe to profound hearing loss. Barriers span psychological, informational,...